Fortified CBD oil for treatment of PTSD

Abstract

A liquid capsule of cannabis, ginseng, and turmeric rhizome oil blend consisting essentially of an oil blend of cannabis oil, turmeric rhizome oil, and ginseng oil in a liquid capsule. There is less than 4 ppm of tetrahydrocannabinol (THC) in the oil blend.

Claims

1. A liquid capsule consisting essentially of cannabis oil, ginseng oil, and turmeric rhizome oil, wherein the oil blend is free of tetrahydrocannabinol.

2. The liquid capsule of claim 1, wherein the oil blend includes 2.5 mg/ml-20 mg/ml of cannabis oil, at least 250 mg/ml of rhizome oil, and at least 20 mg/ml of ginseng oil.

3. The liquid capsule of claim 1, wherein the rhizome oil and ginseng oil are organically grown.

4. The liquid capsule of claim 1, wherein the liquid capsule includes approximately 1 ml of the oil blend.

Description

DETAILED DESCRIPTION

(1) The present disclosure describes a unique blend of Cannabis CBD oil, turmeric oil, and ginseng oil. In particular, the CBD oil is fortified with at least one curcuminoid from turmeric and at least one ginsenoside from Panax ginseng and/or P. quinquefolius. The blended CBD oil composition can be used for treating PTSD as well as other stress-related health conditions, for example. Each of these three ingredients are well-suited for treating PTSD and other stress related conditions since all three have anti-inflammatory, calming, and memory-enhancing properties, and as such, they are able to address the various manifestations of the syndrome.

(2) In the unique formulations discussed herein, each of these three ingredients complements the pharmacology of the others, exhibiting a synergistic effect.

(3) In one example, the blended oil composition includes less than 4 ppm of psychoactive tetrahydrocannabinol (THC). In a further example, the blended oil composition is free of THC.

(4) The blended oil could be administered by prescription by authorized registered licensed physicians for treating PTSD and other stress related health conditions, for example.

(5) The blended oil composition includes a combination of CBD, one or more curcuminoids (e.g., curcumin), and one or more ginsenosides. The CBD is obtained from extracts of Cannabis sativa, including at least one of C. sativa, C. indica, and C. ruderalis including its subspecies, varieties, strains, and biotypes. The CBD is fortified with the curcuminoid(s) from turmeric rhizomes, and ginsenoside(s) from at least one of Panax ginseng and P. quinquefolius. All three of the ingredients are combined to form a synergistic formulation.

(6) The Cannabis plant extracts may be obtained from C. sativa, C. indica and C. ruderalis and/or any of their many sub species, strains, hybrids and biotypes grown in semi-automated, computerized greenhouses. Similarly, the Curcuminoids and ginsenosides from turmeric and ginseng can be purified from organically grown plants.

(7) In the composition of some embodiments, the CBD oil contains a range of cannabinoids ranging from 2.5 mg-20 mg/ml and is fortified with not less than 250 mg/ml of Curcuminoids and 250 mg/ml of ginsenosides. Such fortified CBD oil can be incorporated into various beverages, tonics, liquid capsules, and tinctures. The amount may be varied to suit the needs of differing patients.

(8) In one example, a liquid capsule for oral intake includes 1 ml of the fortified CBD oil. In one example, 1 ml of the fortified CBD oil is included in a 2 ounce dose of a liquid tonic.

(9) One example composition is a beverage including 1 ml of the fortified CBD oil diluted with 8 ounces of liquid emulsion. The beverage in this example is fortified with a selected dosage, such as a minimum daily requirement of vitamins and minerals.

(10) Although example embodiments have been disclosed, a worker of ordinary skill in this art would recognize that certain modifications would come within the scope of this disclosure. For that reason, the following claims should be studied to determine the scope and content of this disclosure.